Myasthenia gravis and a rare complication of chemotherapy.
We describe a patient with myasthenia gravis and thymoma who developed recurrent severe myasthenic crises associated with the use of combination chemotherapy.
Ng
Christina V T
CV
Department of Clinical Oncology, University of Malaya Medical Centre, Jalan Universiti, Lembah Pantai, Kuala Lumpur, Malaysia. christinavtng@hotmail.com
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000209:etiology* / Q000628:therapy; D011729:Pyridostigmine Bromide / Q000008:administration & dosage; D012008:Recurrence; D013945:Thymoma / Q000150:complications* / Q000188:drug therapy*; D013953:Thymus Neoplasms / Q000150:complications* / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors; D005047:Etoposide; D003907:Dexamethasone; D004317:Doxorubicin; D011729:Pyridostigmine Bromide; D002945:Cisplatin